Ancrod enhances the thrombolytic effect of streptokinase and urokinase
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 47 (4) , 417-426
- https://doi.org/10.1016/0049-3848(87)90457-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Usefulness of residual plasma fibrinogen after intravenous streptokinase for predicting delay or failure of reperfusion in acute myocardial infarctionThe American Journal of Cardiology, 1986
- Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.Circulation, 1985
- Relation of effectiveness of intracoronary thrombolysis in acute myocardial infarction to systemic thrombolytic stateThe American Journal of Cardiology, 1985
- Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.Circulation, 1985
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983
- Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.Journal of Clinical Investigation, 1982
- Continued incorporation of circulating radiolabeled fibrinogen into preformed coronary artery thrombi.Circulation, 1977
- Effect of coronary thrombus age on fibrinogen uptake.Circulation, 1976
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957